Ivan Košík

10PUBLICATIONS
84CO-AUTHORS
GlycoconjugatesBiomolecular modelling and designInnate immunityMedical devicesMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 06, 2026
Nanoscopy reveals heparan sulfate clusters as docking sites for SARS-CoV-2 attachment and entry.

|Jul 20, 2026
Viral syncytia evolve to resist interferon.

|Aug 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies.

Victoria Callahan, Matthew S Sutton, Christina L Gardner

|Jul 04, 2025
Mitochondrial dysfunction enhances influenza pathogenesis by up-regulating de novo sialic acid biosynthesis.

Amanda L Fuchs, Bharati Singh, Jillian W Jetmore

|Jul 08, 2024
Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.

Zhe Hu, Alberto Domingo López-Muñoz, Ivan Kosik

|Mar 22, 2024
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire.

Ivan Kosik, Jefferson Da Silva Santos, Mathew Angel

Pageof 2

Frequent Collaborators

8 joint publications

Jonathan Yewdell

3 joint publications

Alberto Domingo López-Muñoz

2 joint publications

Hang Xie

2 joint publications

Julie M Fox